Results 111 to 120 of about 18,089 (204)

Sunshine Act expansion and the prescription of generic medications by advanced practice providers. [PDF]

Health Aff Sch
Nadeem H, Li J, Donovan LM, Feemster LC, Au DH, Duan KI.   +5 more
europepmc   +1 more source

Pharmacoepidemiology of Oxycodone in the USA: An Observational Study of ARCOS, Medicaid, and Medicare Drug Databases. [PDF]

Pharmacol Res Perspect
Solgama JP, Pradhan A, McCall KL, Piper BJ.   +3 more
europepmc   +1 more source

Evaluation of Prescription Practices Using WHO/INRUD Indicators and Determinants of Polypharmacy at a Kenyan County Referral Hospital. [PDF]

Adv Pharmacol Pharm Sci
Kayioni J, Guantai E, Oluka M, Okalebo F.   +3 more
europepmc   +1 more source

Biologicals in the era of biosimilars: implications for naming and prescribing

, 2007
Unlike generics of chemical drugs, biosimilars are similar but not identical to the original product. Therefore, and in relation to their safe use and pharmacovigilance, questions are being raised about the (im)possibility of applying the current INN system for adequate naming of biotherapeutics in general and biosimilars in particular.
openaire   +1 more source

The decision-making processes of UK general practice nurse prescribers when managing acute illness in patients with multimorbidity and polypharmacy: a qualitative study using think aloud and staged vignettes. [PDF]

Prim Health Care Res Dev
Herklots A, Latter S, McLean C.
europepmc   +1 more source

Antibiotic prescribing patterns using World Health Organization/International Network for Rational Use of Drug prescribing indicators and its determinants in Eastern Tigrai, Ethiopia: A need for antimicrobial stewardship programs. [PDF]

SAGE Open Med
Hailesilase GG, Gebrezgabiher HA, Welegebrial BG, Kidane AM.   +3 more
europepmc   +1 more source

Antibiotics Use Patterns in Low- and Middle-Income Countries: A Systematic Review Analysis. [PDF]

Inquiry
Nepal A, Bhandari N, Subedi R, Hendrie D.   +3 more
europepmc   +1 more source

Treatment Sequencing and Line of Therapy for Biologics and JAK inhibitors in Rheumatoid Arthritis Patients: Implications for Design and Uptake of New Drugs and Predictive Biomarker Diagnostics. [PDF]

Arthritis Care Res (Hoboken)
Curtis JR, Daigle S, Holladay EE, Su Y, George M, Lam G, Levin R, Reddy P, Xie F, Mudano AS.   +9 more
europepmc   +1 more source

A cross-sectional evaluation of rational antibiotic prescribing in Kabul based on WHO indicators. [PDF]

BMC Infect Dis
Ehsan H, Ibrahimkhil MA, Ahmadi M, Wardak FR, Aminpoor H, Salam A, Tariq H, Mubarak MY.   +7 more
europepmc   +1 more source

Evolving health policy and regulatory oversight of medicinal cannabis in Australia: lessons for sustainable integration. [PDF]

J Cannabis Res
Lim ECN, Lim CED.
europepmc   +1 more source